Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGL NYSE:CON NASDAQ:SGRY NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLAgilon Health$1.82+6.8%$2.19$1.50▼$6.63$703.72M0.142.68 million shs3.86 million shsCONConcentra Group Holdings Parent$19.79+1.6%$20.72$18.89▼$24.81$2.50BN/A780,682 shs485,982 shsSGRYSurgery Partners$22.22+4.4%$22.18$18.87▼$33.97$2.73B1.821.48 million shs1.81 million shsWGSGeneDx$108.35+6.6%$80.76$25.32▼$117.75$2.90B2.021.01 million shs924,686 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLAgilon Health+7.08%-8.79%-24.25%-59.53%-71.37%CONConcentra Group Holdings Parent+1.54%-1.30%-3.75%-8.89%-12.63%SGRYSurgery Partners+4.42%-0.98%+0.32%-3.43%-23.56%WGSGeneDx+6.64%+27.61%+18.27%+71.25%+260.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGLAgilon Health1.6351 of 5 stars3.13.00.00.01.60.00.6CONConcentra Group Holdings Parent2.8842 of 5 stars3.50.02.50.02.00.01.3SGRYSurgery Partners2.9679 of 5 stars3.41.00.00.03.70.02.5WGSGeneDx3.0364 of 5 stars1.44.00.00.03.15.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGLAgilon Health 2.17Hold$4.71159.74% UpsideCONConcentra Group Holdings Parent 3.00Buy$28.5044.01% UpsideSGRYSurgery Partners 2.70Moderate Buy$33.3350.02% UpsideWGSGeneDx 2.75Moderate Buy$101.63-6.21% DownsideCurrent Analyst Ratings BreakdownLatest AGL, SGRY, CON, and WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/4/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$110.00 ➝ $120.007/30/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$78.00 ➝ $95.007/28/2025SGRYSurgery PartnersBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$28.007/9/2025AGLAgilon HealthEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$5.00 ➝ $3.007/9/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$110.006/30/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$88.00 ➝ $115.005/27/2025SGRYSurgery PartnersBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$25.00 ➝ $24.005/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/13/2025AGLAgilon HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$6.00 ➝ $5.005/9/2025WGSGeneDxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$80.005/8/2025AGLAgilon HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.00(Data available from 8/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGLAgilon Health$6.06B0.12N/AN/A$1.14 per share1.59CONConcentra Group Holdings Parent$1.90B1.33$1.88 per share10.55$2.20 per share9.00SGRYSurgery Partners$3.11B0.91$1.96 per share11.36$25.15 per share0.88WGSGeneDx$362.32M8.53$1.09 per share99.29$8.75 per share12.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGLAgilon Health-$260.15M-$0.59N/AN/AN/A-4.04%-45.47%-12.76%8/5/2025 (Estimated)CONConcentra Group Holdings Parent$166.54M$1.3414.7715.221.748.09%29.94%6.31%8/7/2025 (Confirmed)SGRYSurgery Partners-$168.10M-$1.53N/A27.43N/A-6.10%2.41%0.99%8/5/2025 (Estimated)WGSGeneDx-$52.29M$0.052,167.0051.84N/A0.39%16.51%9.35%N/ALatest AGL, SGRY, CON, and WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025CONConcentra Group Holdings Parent$0.37N/AN/AN/A$537.36 millionN/A8/5/2025Q2 2025SGRYSurgery Partners$0.16N/AN/AN/A$816.96 millionN/A8/4/2025Q2 2025AGLAgilon Health-$0.11-$0.25-$0.14-$0.25$1.47 billion$1.39 billion7/29/2025Q2 2025WGSGeneDx$0.10$0.50+$0.40$0.36$86.00 million$102.69 million5/12/2025Q1 2025SGRYSurgery Partners$0.08$0.04-$0.04-$0.30$777.77 million$776.00 million5/7/2025Q1 2025CONConcentra Group Holdings Parent$0.31$0.32+$0.01$0.30$496.06 million$500.80 million5/6/2025Q1 2025AGLAgilon Health-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGLAgilon HealthN/AN/AN/AN/AN/ACONConcentra Group Holdings Parent$0.251.26%N/A18.66%N/ASGRYSurgery PartnersN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ALatest AGL, SGRY, CON, and WGS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2025CONConcentra Group Holdings Parentquarterly$0.06251.2%5/20/20255/20/20255/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGLAgilon HealthN/A1.201.20CONConcentra Group Holdings Parent5.181.101.10SGRYSurgery Partners1.091.891.73WGSGeneDx0.192.872.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGLAgilon HealthN/ACONConcentra Group Holdings ParentN/ASGRYSurgery PartnersN/AWGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipAGLAgilon Health3.57%CONConcentra Group Holdings Parent6.60%SGRYSurgery Partners2.30%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGLAgilon Health1,076413.95 million399.17 millionNot OptionableCONConcentra Group Holdings Parent11,250128.17 million119.71 millionN/ASGRYSurgery Partners15,000128.16 million125.21 millionOptionableWGSGeneDx1,20028.53 million20.09 millionOptionableAGL, SGRY, CON, and WGS HeadlinesRecent News About These CompaniesRosen Law Firm Encourages GeneDx Holdings Corp. ...August 3 at 1:43 PM | gurufocus.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSAugust 3 at 12:43 PM | prnewswire.comGeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Buy RatingAugust 3 at 3:44 AM | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. ...August 2 at 1:17 PM | gurufocus.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsAugust 2 at 12:52 PM | globenewswire.com15,317 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Universal Beteiligungs und Servicegesellschaft mbHAugust 2 at 4:50 AM | marketbeat.comWells Fargo & Company Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) StockAugust 2 at 2:07 AM | americanbankingnews.comKevin Feeley Sells 388 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockAugust 1, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $226,837.74 in StockAugust 1, 2025 | marketbeat.comVictory Capital Management Inc. Purchases 12,945 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)August 1, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $40,860.28 in StockAugust 1, 2025 | insidertrades.comGeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End GrowthJuly 31, 2025 | seekingalpha.comGeneDx Target of Unusually Large Options Trading (NASDAQ:WGS)July 31, 2025 | marketbeat.comWells Fargo & Company Issues Positive Forecast for GeneDx (NASDAQ:WGS) Stock PriceJuly 31, 2025 | marketbeat.comWGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law GroupJuly 31, 2025 | prnewswire.comWhy GeneDx Holdings Stock Crushed It Again TodayJuly 30, 2025 | fool.comGeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law FirmJuly 30, 2025 | globenewswire.comGeneDx (NASDAQ:WGS) Shares Gap Up Following Strong EarningsJuly 30, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Announces Quarterly Earnings ResultsJuly 30, 2025 | marketbeat.comGeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more optionsJuly 30, 2025 | youtube.comYEarnings To Watch: GeneDx Holdings Corp (WGS) Reports Q2 2025 ResultJuly 30, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesThis Drone Stock Is on Sale Despite Big Army ContractBy Jeffrey Neal Johnson | July 31, 2025View This Drone Stock Is on Sale Despite Big Army Contract3 Catalysts Driving Plug Power’s Turnaround CaseBy Jeffrey Neal Johnson | July 18, 2025View 3 Catalysts Driving Plug Power’s Turnaround CaseWhy the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 2025View Why the American Eagle Stock Rally Isn't Just Speculation Congress Is Dumping These 5 Stocks—Should You Follow?By Thomas Hughes | July 25, 2025View Congress Is Dumping These 5 Stocks—Should You Follow?D-Wave Is Rising Again Despite Dilution—What’s the Deal?By Nathan Reiff | July 7, 2025View D-Wave Is Rising Again Despite Dilution—What’s the Deal?AGL, SGRY, CON, and WGS Company DescriptionsAgilon Health NYSE:AGL$1.82 +0.12 (+6.76%) Closing price 08/4/2025 03:40 PM EasternExtended Trading$1.41 -0.40 (-22.09%) As of 05:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Concentra Group Holdings Parent NYSE:CON$19.79 +0.31 (+1.59%) Closing price 08/4/2025 03:59 PM EasternExtended Trading$20.09 +0.30 (+1.52%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.Surgery Partners NASDAQ:SGRY$22.22 +0.94 (+4.42%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$22.22 0.00 (-0.02%) As of 08/4/2025 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.GeneDx NASDAQ:WGS$108.35 +6.75 (+6.64%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$108.20 -0.15 (-0.14%) As of 05:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas How 2 Deals in 48 Hours Changed Everything for Joby Aviation Here's Why Traders Turned Bullish on Boeing Stock Onsemi’s August Pullback Is a Signal to Buy for Tech Investors Strategy Insiders Buy In While Analysts Predict Big Upside Analysts Make a Quantum Bet on D-Wave's Cryogenic Packaging Yes, You Can Get Dividends in Tech: 3 Stocks With Yield + Upside MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
